Clinical Trials

Showing trials with last updates posted in 2020.

NCT03106077 | COMPLETED | PHASE2
96 participants

Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2020-12-02
Start Date:
2017-06-05
Completion:
2019-10-01
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Estrogen Receptor Negative
  • Folate Receptor Alpha Positive
  • HER2/Neu Negative
  • Progesterone Receptor Negative
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Triple-Negative Breast Carcinoma
Interventions
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page